Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series

Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series

Abstract Objectives To present our experience with ammonium tetrathiomolybdate (ATTM) in the decoppering phase treatment of Wilson's disease (WD) with neurological symptoms. Methods An uncontrolled longitudinal study was carried out to describe a case series of five patients diagnosed of WD wit...

Full description

Bibliographic Details
Main Authors: Oriol De Fabregues, Jaume Viñas, Antoni Palasí, Manuel Quintana, Ignasi Cardona, Cristina Auger, Víctor Vargas
Format: Article
Language:English
Published: Wiley 2020-05-01
Series:Brain and Behavior
Subjects:
ammonium tetrathiomolybdate
efficacy
neurological symptoms
safety
Wilson's disease
Online Access:https://doi.org/10.1002/brb3.1596

Internet

https://doi.org/10.1002/brb3.1596

Similar Items